The Liverpool Heart and Chest Hospital is a National Health Service hospital in Liverpool. It is one of several specialist hospitals located within the Liverpool City Region, alongside Liverpool Women's ...

There are 187 beds in Liverpool Heart and Chest Hospital.

During the past decade, Liverpool Heart and Chest Hospital conducted 70 clinical trials. In the 10-year time frame, 70 clinical trials started and 20 clinical trials were completed, i.e. on average, 28.6% percent of trials that started reached the finish line to date. In the past 5 years, 28 clinical trials started and 14 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Liverpool Heart and Chest Hospital" #1 sponsor was "Liverpool Heart and Chest Hospital NHS Foundation Trust" with 15 trials, followed by "Boston Scientific Corporation" with 8 trials sponsored, "Medtronic Cardiac Rhythm and Heart Failure" with 8 trials sponsored, "Vertex Pharmaceuticals Incorporated" with 7 trials sponsored and "Medtronic" with 7 trials sponsored. Other sponsors include 44 different institutions and companies that sponsored additional 45 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Liverpool Heart and Chest Hospital" #1 collaborator was "Liverpool Heart and Chest Hospital NHS Foundation Trust" with 5 trials as a collaborator, "Royal Brompton & Harefield NHS Foundation Trust" with 4 trials as a collaborator, "Edge Hill University" with 3 trials as a collaborator, "National Institute for Health Research, United Kingdom" with 3 trials as a collaborator and "University Hospitals, Leicester" with 3 trials as a collaborator. Other collaborators include 66 different institutions and companies that were collaborators in the rest 68 trials.

According to Clinical.Site data, the most researched conditions in "Liverpool Heart and Chest Hospital" are "Cystic Fibrosis" (18 trials), "Atrial Fibrillation" (11 trials), "Heart Failure" (7 trials), "Coronary Artery Disease" (4 trials) and "Myocardial Infarction" (3 trials). Many other conditions were trialed in "Liverpool Heart and Chest Hospital" in a lesser frequency.

Most popular intervention types in "Liverpool Heart and Chest Hospital" are "Drug" (36 trials), "Device" (30 trials), "Other" (13 trials), "Procedure" (12 trials) and "Behavioral" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (11 trials), "IVA" (7 trials), "ELX/TEZ/IVA" (4 trials), "Apixaban" (3 trials) and "Apixaban matching placebo" (2 trials). Other intervention names were less common.

The vast majority of trials in "Liverpool Heart and Chest Hospital" are 92 trials for "All" genders.

Currently, there are NaN active trials in "Liverpool Heart and Chest Hospital". undefined are not yet recruiting, 15 are recruiting, 11 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 52 completed trials in Liverpool Heart and Chest Hospital, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Liverpool Heart and Chest Hospital, 1 "Phase 1" clinical trials were conducted, 13 "Phase 2" clinical trials and 12 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 7 trials, and there were also 35 trials that are defined as “Not Applicable".